Sonoma offers safe early-intervention solutions that provide fast relief and are free from side effects and other limitations.
Sonoma Pharmaceuticals is a global healthcare leader dedicated to developing and commercializing innovative wound care and dermatological solutions. With over 20 years of experience, we have harnessed the power of our patented Microcyn Technology to create a diverse product portfolio that addresses the needs of patients and healthcare professionals alike.
Our mission is to improve patient outcomes by providing access to reliable, unique solutions that facilitate optimal conditions for wound care and skin health. We collaborate with the brightest minds in the industry and partner with our community to bring groundbreaking products to market, constantly pushing the boundaries of what’s possible in healthcare.
Up to 90% verified emails and mobile numbers, refreshed weekly.
Sonoma Pharmaceuticals operates in the Pharmaceutical Manufacturing industry and is headquartered in United States.
Sonoma Pharmaceuticals has approximately 51-200 employees employees.
Sonoma Pharmaceuticals is based in Boulder, CO, United States.
Yes. Sonoma Pharmaceuticals is a publicly traded company.
You can reach Sonoma Pharmaceuticals’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.